Diego S. Ojeda
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Sustained superior humoral immune responses of mRNA vaccines compared to Sputnik V viral vector COVID-19 vaccines in naïve and convalescent populations.
Journal: Vaccine
Published: August 23, 2025
Dengue virus NS5 degrades ERC1 during infection to antagonize NF-kB activation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 30, 2023
Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina.
Journal: Frontiers in immunology
Published: July 12, 2022
HIV-induced bystander cell death in astrocytes requires cell-to-cell viral transmission.
Journal: Journal of neurochemistry
Published: July 04, 2022
Comparative analysis of humoral immune response upon the three first vaccines applied in Argentina: IgG production and neutralizing capacity against SARS-CoV-2.
Journal: Heliyon
Published: June 02, 2022
Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people.
Journal: The Lancet. Infectious diseases
Published: May 16, 2022
Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response.
Journal: The Journal of infectious diseases
Published: May 03, 2022
SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants.
Journal: Frontiers in immunology
Published: March 31, 2022
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273.
Journal: Cell reports. Medicine
Published: March 30, 2022
Antibody durability at 1 year after Sputnik V vaccination.
Journal: The Lancet. Infectious diseases
Published: February 25, 2022
Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time.
Journal: mBio
Published: January 25, 2022
Last Updated: 09/26/2026